Irr

Byju’s, Pharmeasy among biggest underperformers in Prosus' India portfolio in H1

According to the firm’s half yearly financials, while Byju’s reported a negative internal rate of return (IRR) of 24 percent, Pharmaeasy gave Prosus 41 percent negative returns in H1 FY24.

Intense competition to limit growth potential of solar IPPs

Solar power projects under different state policies have been competitively bid and awarded at a tariff of about Rs. 6.5 per unit. This levelised tariff is significantly lower than Rs. 9.4 per unit, a level we believe is required to achieve reasonable equity internal rate of return (IRR) of, say, 16 per cent: CRISIL.

Indian Property Advisors to raise $300m offshore fund

Ramesh Jogani of IPAL spoke to CNBC-TV18 regarding the fund rasing of around Rs 2000 crore that the company is planning to do both via domestic as well offshore funds.

Proton Therapy project to begin by FY18: Apollo Hospital

Apollo Hospital will soon establish a Proton Therapy Center in Tamil Nadu that will augment cancer offering to patients and is likely to be commissioned by FY18, CFO Akhileshwaran Krishnan told CNBC-TV18.

Sebi clears KFA loan sell-off, CCI yet to approve: SREI

SREI Infra announced that it is keen to offload the United Spirits (USL) shares it holds as underlying security on the 430 crore Kingfisher loan it bought from ICICI Bank. Sunil Kanoria, CMD, SREI Infra spoke to CNBC-TV18 regarding the KFA collateral sale plans.

CV loans at high interest rate may default: India Ratings

India Ratings has come out with its special report on "CV loans at high interest rate or of low ticket size more prone to default". According to the rating agency, deploying higher interest rates is not a mitigating factor sufficient to address the risk associated with loss severity in CV loans.

Don't see stiff competition until inflation cools: ITNL

A lot of bidding companies in the infrastructure sector are facing intense competition in the last one year. K Ramchand, MD of ITNL tells CNBC-TV18 that however the competition is reducing in the space because of adverse condition like interest rates.

Looking at all fund raising options, says SBI

Banking companies have been under the scanner in the past week due to worries of poor asset quality, especially in the infrastructure space. But, Santosh Nair, deputy managing director - corporate banking, State Bank of India says that they will not be focusing on bad loans right away.